Effect of ergotamine on plasma metabolite and insulin-like growth factor-1 concentrations in cows

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 135, Issue 1, 2003, Pages 1-9

  Browning Jr , Richard ^a  

^a TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Cattle; Cholesterol; Ergotamine; Ergotism; Glucose; Hyperglycemia; Insulin like growth factor 1 (IGF 1); Plasma metabolites; Triglycerides

Indexed keywords

CHOLESTEROL; ERGOTAMINE TARTRATE; GLUCOSE; NORGESTOMET; PROSTAGLANDIN; SODIUM CHLORIDE; SOMATOMEDIN C; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BLOOD COMPONENT; BOLUS INJECTION; CATTLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COW; CROSSOVER PROCEDURE; DRUG EFFECT; EAR; GLUCOSE BLOOD LEVEL; IMPLANT; LUTEOLYSIS; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TIME; TRIACYLGLYCEROL BLOOD LEVEL;

BOS TAURUS; BOVINAE;

EID: 0038350839     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1532-0456(03)00048-6     Document Type: Article

References (49)

1. Badia A., Moron A., Cuffi L., Vila E. Effects of ergotamine on cardiovascular catecholamine receptors in the pithed rat. Gen. Pharmacol. 19:1988;475-481.
2. Bereket A., Lang C.H., Wilson T.A. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm. Metab. Res. 31:1999;172-181.
3. Blum J.W., Froehli D., Kunz P. Effects of catecholamines on plasma free fatty acids in fed and fasted cattle. Endocrinology. 110:1982;452-456.
4. Braird N., Dadoun F., Pommier G., Sauze N., Lebouc Y., Oliver C., Dutour A. IGF-I/IGFBPs system response to endotoxin challenge in sheep. J. Endocrinol. 164:2000;361-369.
5. Browning R. Jr. Physiological responses of Brahman and Hereford steers to an acute 16 ergotamine challenge. J. Anim. Sci. 78:2000;124-130.
6. Browning R. Jr, Leite-Browning M.L. Effect of ergotamine and ergonovine on thermal regulation and cardiovascular function in cattle. J. Anim. Sci. 75:1997;176-181.
7. Browning R. Jr, Thompson F.N. Endocrine and respiratory responses to ergotamine in Brahman and Hereford steers. Vet. Hum. Toxicol. 44:2002;149-154.
8. Browning R. Jr, Thompson F.N., Sartin J.L., Leite-Browning M.L. Plasma concentrations of prolactin, growth hormone, and luteinizing hormone in steers administered ergotamine or ergonovine. J. Anim. Sci. 75:1997;796-802.
9. Browning R. Jr, Leite-Browning M.L., Smith H.M., Wakefield T. Jr. Effect of ergotamine and ergonovine on plasma concentrations of thyroid hormones and cortisol in cattle. J. Anim. Sci. 76:1998;1644-1650.
10. Browning R. Jr, Gissendanner S.J., Wakefield T. Jr. Ergotamine alters plasma concentrations of glucagon, insulin, cortisol, and triiodothyronine in cows. J. Anim. Sci. 78:2000;690-698.
11. Browning R. Jr, Schrick F.N., Thompson F.N., Wakefield T. Jr. Effect of an acute ergotamine challenge on reproductive hormones in follicular phase heifers and progestin-treated cows. Anim. Reprod. Sci. 66:2001;135-149.
12. 3H] dihydroergocryptine binding. Arch. Int. Pharmacodyn. Ther. 246:1980;237-250.
13. Davenport G.M., Boling J.A., Rahe C.H. Growth and endocrine responses of cattle to implantation of estradiol-17β during continuous or discontinuous grazing of high- and low-endophyte-infected tall fescue. J. Anim. Sci. 71:1993;757-764.
14. DiTullio N.W., Cieslinski L., Matthews W.D., Storer B. Mechanisms involved in the hyperglycemic response induced by clonidine and other alpha-2 adrenoceptor agonists. J. Pharmacol. Exp. Ther. 228:1984;168-173.
15. Durrington P.N. Diabetic dyslipidaemia. Bailliere's Clin. Endocrinol. Metab. 13:1999;265-278.
16. Filipov N.M., Thompson F.N., Stuedemann J.A., Elsasser T.H., Kahl S., Sharma R.P., et al. Increasesd responsiveness to intravenous lipopolysaccharide challenge in steers grazing endophyte-infected tall fescue compared with steers grazing endophyte-free tall fescue. J. Endocrinol. 163:1999;213-220.
17. Filipov N.M., Thompson F.N., Stuedemann J.A., Elsasser T.H., Kahl S., Stanker L.H., et al. Anti-inflammatory effects of ergotamine in steers. Proc. Soc. Exp. Biol. Med. 225:2000;136-142.
18. Graham A.N., Johnson E.S., Persaud N.P., Turner P., Wilkenson M. Ergotamine toxicity and serum concentrations of ergotamine in migraine patients. Human Toxicol. 3:1984;193-199.
19. Haddjeri N., Seletti B., Gilbert F., de Montigny C., Blier P. Effect of ergotamine on serotonin-mediated responses in the rodent and human brain. Neuropsychopharmacology. 19:1998;365-380.
20. Haffner S.M. Management of dyslipidemia in adults with diabetes. Diabetes Care. 21:1998;160-178.
21. Hanaire-Broutin H., Sallerin-Caute B., Poncet M.F., Tauber M., Bastide R., Rosenfeld R., et al. Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization. Diabetes Metab. 22:1996;45-50.
22. Hill N.S., Thompson F.N., Stuedemann J.A., Rottinghaus G.W., Ju H.J., Dawe D.L., Hiatt E.E. 3rd. Ergot alkaloid transport across ruminant gastric tissues. J. Anim. Sci. 79:2001;542-549.
23. Himms-Hagen J. Effects of catecholamines on metabolism. Blaschko H., Muscholl E. Handbook of Experimental Pharmacology, vol. 133. 1972;363-462 Springer-Verlag, Berlin.
24. Kasuya E., Hodate K., Matsumoto M., Sakaguchi M., Hashizume T., Kanematsu S. The effects of xylazine on plasma concentrations of growth hormone, insulin-like growth factor-1, glucose and insulin in calves. Endocr. J. 43:1996;145-149.
25. Lafontan M., Berlan M. Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr. Rev. 16:1995;716-738.
26. Lang C.H., Pollard V., Fan J., Traber L.D., Traber D.L., Frost R.A., et al. Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am. J. Physiol. 273:1997;R371-378.
27. Larson B.T., Harmon D.L., Piper E.L., Griffis L.M., Bush L.P. Alkaloid binding and activation of D2 dopamine receptors in cell culture. J. Anim. Sci. 77:1999;942-947.
28. Li Y.H., Fan J., Lang C.H. Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBB-1. Am. J. Physiol. 272:1997;R1990-1997.
29. Martins I., Blau J.N. Headaches in insulin-dependent diabetic patients. Headache. 29:1989;660-663.
30. Meijer G.W., Janssen G.B., Beynen A.C., Speijers G.J.A. Is dietary ergotamine atherogenic in the rabbit? Food. Chem. Toxicol. 30:1992;731-734.
31. Oliver J.W., Schultze A.E., Rohrbach B.W., Fribourg H.A., Ingle T., Waller J.C. Alterations in hemograms and serum biochemical analytes of steers after prolonged consumption of endophyte-infected tall fescue. J. Anim. Sci. 78:2000;1029-1035.
32. Osborn T.G., Schmidt S.P., Marple D.N., Rahe C.H., Steenstra J.R. Effect of consuming fungus-infected and fungus-free tall fescue and ergotamine tartrate on selected physiological variables of cattle in environmentally controlled conditions. J. Anim. Sci. 70:1992;2501-2509.
33. Ozawa A., Johke T., Hodate K. Effect of alpha 2-adrenergic agonist clonidine on plasma growth hormone and insulin-like growth factor-1 concentrations in barrows. Endocrinol. J. 42:1995;669-673.
34. Paterson J., Forcherio C., Larson B., Samford M., Kerley M. The effects of fescue toxicosis on beef cattle productivity. J. Anim. Sci. 73:1995;889-898.
35. Porter J.K. Chemical constituents of grass endophytes. Bacon C.W., White J.F. Jr. Biotechnology of Endophytic Fungi of Grasses. 1994;103-123 CRC Press, Boca Raton, FL.
36. Pullinger C.R., Gibbons G.F. Effects of hormones and pyruvate on the rates of secretion of very-low-density lipoprotein triacylglycerol and cholestereol by rat hepatocytes. Biochim. Biophys. Acta. 833:1985;44-51.
37. Roquebert J., Grenie B. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats. Arch. Int. Pharmacodyn. Ther. 284:1986;30-37.
38. Scholtysik G., Regli F., Bruckmaier R.M., Blum J.W. The alpha 2-adrenoceptor agonists xylazine and guanfacine exert different central nervous system, but comparable peripheral effects in calves. J. Vet. Pharmacol. Ther. 21:1998;477-484.
39. Silberstein S.D. The pharmacology of ergotamine and dihydroergotamine. Headache. 37:(Suppl 1):1997;S15-S25.
40. Silberstein S.D., Young W.B. Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology. 45:1995;577-584.
41. Split W., Szydlowska M. Headaches in non-insulin-dependent diabetes mellitus. Funct. Neurol. 12:1997;327-332.
42. Steen W.W., Gay N., Boling J.A., Buckner R.C., Bush L.P., Lacefield G. Evaluation of Kentucky 31, GI-306, GI-307, and Kenhy tall fescue as pasture for yearling steers. II. Growth, physiological responses, and plasma constituents of yearling steers. J. Anim. Sci. 48:1979;618-623.
43. Sticker L.S., Thompson D.L., Bunting L.D., Fernandez J.M., DePew C.L. Dietary protein and(or) energy restriction in mares: plasma glucose, insulin, non-esterified fatty acid, and urea nitrogen responses to feeding, glucose and epinephrine. J. Anim. Sci. 73:1995;136-144.
44. Stuedemann J.A., Rumsey T.S., Bond J., Wilkerson S.R., Bush L.P., Williams D.J., et al. Association of blood cholesterol with occurrence of fat necrosis in cows and tall fescue summer toxicosis in steers. Am. J. Vet. Res. 46:1985;1990-1995.
45. Tan K., Baxter R.C. Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J. Clin. Endocrinol. Metab. 63:1986;651-655.
46. TePaske M.R., Powell R.G., Clement S.L. Analyses of selected endophyte-infected grasses for the presence of loline-type and ergot-type alkaloids. J. Agric. Food Chem. 41:1993;2299-2303.
47. Tfelt-Hansen P., Saxena P.R., Dahlof C., Pascual J., Lainez M., Henry P., et al. Ergotamine in the acute treatment of migraine, a review and European consensus. Brain. 123:2000;9-18.
48. Yamauchi T., Iwai M., Kobayashi N., Shimazu T. Noradrenaline and ATP decrease the secretion of triglyceride and apoprotein B from perfused rat liver. Pflugers Archiv. 435:1998;368-374.
49. Zammit V.A. Use of in vivo and in vitro techniques for the study of the effects on insulin on hepatic triacylglycerol secretion in different insulinaemic states. Biochem. Soc. Trans. 28:2000;103-109.